ResearcherNo recent work listed

Sushanth Reddy

Provisional: name only (low confidence, 0.40), identity_conf@1As of 7 November 2026

Known by name only; no external author ID or institution yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. Last author DOI 10.1097/mpa.0000000000001972 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Selwyn Maurice Vickers · 1 shared paper, 2022 · strength 0.17
- Paper The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. DOI 10.1097/mpa.0000000000001972 ↗
Ahmer Irfan · 1 shared paper, 2022 · strength 0.17
- Paper The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. DOI 10.1097/mpa.0000000000001972 ↗
John Bart Rose · 1 shared paper, 2022 · strength 0.17
- Paper The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. DOI 10.1097/mpa.0000000000001972 ↗
Olumide B. Gbolahan · 1 shared paper, 2022 · strength 0.17
- Paper The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. DOI 10.1097/mpa.0000000000001972 ↗
Vikas Dudeja · 1 shared paper, 2022 · strength 0.17
- Paper The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy. DOI 10.1097/mpa.0000000000001972 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.